DeLaval
Buying intent
30 tracked signals | Top 15 topics are below | Operations and Product are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere DeLaval's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
18d ago
19d ago
17d ago
17d ago
20d ago
10d ago
23d ago
19d ago
28d ago
17d ago
26d ago
19d ago
19d ago
19d ago
12d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at DeLaval
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileOur vision is to make sustainable food production possible. We support our customers in reducing their environmental footprint while improving food production, profitability and the well-being of the people and animals involved. We design, manufacture and supply integrated milking solutions with the needs of dairy farmers in mind. At all times. We serve customers in more than 100 countries globa
Top accounts researching DeLaval
names withheld on the public pageThese are companies whose own people brought up DeLaval unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
151,426 companies · 839,012 people are researching Artificial Intelligence
DeLaval's own team shows 2 signals on this topic. No one outside DeLaval has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Centers for Medicare and Medicaid Services (CMS)609 cos · 1,450 people
- Microsoft Teams Room48 cos · 136 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Product — 2 people; Sales — 2 people; Operations — 1 person
What's been said
public posts by DeLaval's teamNo public post naming DeLaval has surfaced in the past year, so this is what DeLaval's own team is posting about publicly — their topics, in their words.
Clinicians should be using Claude Cowork more than they are. I get a ton of physicians and health system leaders asking: how do I use AI when I can't integrate into my EHR? Fair question, consumer tools like Claude Cowork and other AI platforms aren't HIPAA-compliant (without enterprise license), and Doximity Ask and OpenEvidence have dominated clinician attention for HIPAA compliant work outside the EHR. However, there are SO many use cases that are applicable to clinicians. CME tracking. CV self-updates. Weekly literature digests. Conference and trip planning. Manuscript pre-review on a flight home. Triaging the half of your inbox that has nothing to do with patients. Drafting a talk before grand rounds. Pulling together a faculty dossier before promotion review. I think these use cases can compound across a career, and most clinicians are still doing them by hand (or paying someone to organize these things for them). I wrote a guide for the difference between dispatch, scheduled tasks, and live artifacts, the three modes that together make up my agentic-like workflow in Claude: — Dispatch: one-time sizeable tasks executed while you're away — Scheduled Tasks: the standing meeting that never cancels — Live Artifacts: pages that re-render from your connectors on open Full guide in comments with prompt guide! What other use cases are the doctors out there leveraging these tools for?
May 2026I had an incredible time on the Withings webinar, discussing what the CMS Access Model could be solving for and how hospitals and health systems should think about the model. With a little over a month to go until the program goes live, I think there is incredible potential in this program, as well as pitfalls to avoid. It has been encouraging for me to see the number of organizations deciding to work with us at MSK Access and RevelAi Health to offer this novel digital health benefit to their Medicare patients. We all need to have a more thoughtful customer-centric approach to care (yes, customer— to take the approach Baylor Scott White CEO Peter McCanna)— And the CMS Access model is a clear wedge to provide technology-enabled services that can fill this gap for health systems and ACOs. Looking forward to everyone else's thoughts on this program and seeing how it evolves over time.
May 2026